The diagnostic value of cerebrospinal fluid tau protein in dementing and nondementing neuropsychiatric disorders. (Q51926890)

17 April 2018

title

The diagnostic value of cerebrospinal fluid tau protein in dementing and nondementing neuropsychiatric disorders. (English)

1 reference

17 April 2018

0 references

George P Paraskevas

1

1 reference

17 April 2018

Elisabeth Kapaki

2

1 reference

17 April 2018

Ioannis Liappas

3

1 reference

17 April 2018

Ioulia Theotoka

4

1 reference

17 April 2018

Ioanna Mamali

5

1 reference

17 April 2018

Christos Zournas

6

1 reference

17 April 2018

Lefteris Lykouras

7

1 reference

17 April 2018

publication date

1 September 2005

1 reference

17 April 2018

Journal of Geriatric Psychiatry and Neurology

published in

1 reference

17 April 2018

volume

18

1 reference

17 April 2018

issue

3

1 reference

17 April 2018

page(s)

163-173

1 reference

17 April 2018

CSF markers for incipient Alzheimer's disease

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0891988705277549

Clinical-neuropathological correlations in Alzheimer's disease and related dementias

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705277549

Incorrect diagnosis of Alzheimer's disease. A clinicopathologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705277549

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705277549

Research evaluation and diagnosis of probable Alzheimer's disease over the last two decades: I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705277549

Neuropathological findings in patients with clinical diagnoses of probable Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705277549

The St. George's dementia bed investigation study: a comparison of clinical and pathological diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705277549

Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705277549

Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705277549

Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705277549

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705277549

Consensus statement on the diagnosis of multiple system atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705277549

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705277549

Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705277549

Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705277549

Cerebrospinal fluid tau in dementia disorders: a large scale multicenter study by a Japanese study group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705277549

Cerebrospinal fluid phospho-tau, total tau and beta-amyloid(1-42) in the differentiation between Alzheimer's disease and vascular dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705277549

Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705277549

Levels of total tau and tau protein phosphorylated at threonine 181 in patients with incipient and manifest Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705277549

Combination assay of CSF tau, A beta 1-40 and A beta 1-42(43) as a biochemical marker of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705277549

Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sample.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705277549

Cerebrospinal fluid markers in dementia with lewy bodies compared with Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705277549

Tau protein concentrations in cerebrospinal fluid of non-demented Parkinson's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705277549

Increased CSF tau protein in corticobasal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705277549

A comparison of tau protein in cerebrospinal fluid between corticobasal degeneration and progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705277549

Tau protein in cerebrospinal fluid (CSF): a blood-CSF barrier related evaluation in patients with various neurological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705277549

Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705277549

Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705277549

Tau protein pathology in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705277549

Increased tau in the cerebrospinal fluid of patients with frontotemporal dementia and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705277549

Tau protein concentrations in cerebrospinal fluid of patients with dementia of the Alzheimer type

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705277549

Tau in cerebrospinal fluids: establishment of the sandwich ELISA with antibody specific to the repeat sequence in tau.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705277549

Expansion of a novel CAG trinucleotide repeat in the 5' region of PPP2R2B is associated with SCA12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705277549

Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705277549

Tau protein in the glial cytoplasmic inclusions of multiple system atrophy can be distinguished from abnormal tau in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705277549

Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705277549

Highly increased CSF tau protein and decreased beta-amyloid (1-42) in sporadic CJD: a discrimination from Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705277549

Discriminant power of combined cerebrospinal fluid tau protein and of the soluble interleukin-6 receptor complex in the diagnosis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705277549

CSF tau protein and beta-amyloid (1-42) in Alzheimer's disease diagnosis: discrimination from normal ageing and other dementias in the Greek population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705277549

Biochemical diagnosis of Alzheimer disease by measuring the cerebrospinal fluid ratio of phosphorylated tau protein to beta-amyloid peptide42.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705277549

Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease” 11The names of the Working Group Members and the names of the Working Group Advisory Committee Members are listed in the Appendix A(section VI)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705277549

Tau Protein in Cerebrospinal Fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705277549

21 January 2018

Identifiers

DOI

10.1177/0891988705277549

1 reference

17 April 2018

1 reference

17 April 2018